Cited by 6,552Cardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Open access

Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Packer, Douglas L., Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E., Clapp-Channing, Nancy, Davidson-Ray, Linda D., Fraulo, Elizabeth S., Fishbein, Daniel P., Luceri, Richard M., Ip, John H.·2005·New England Journal of Medicine

DOI 10.1056/nejmoa043399

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter-defibrillator (ICD) has been proposed to improve the prognosis in such patients. METHODS: We randomly assigned 2521 patients with New York Heart Association (NYHA) class II or III CHF and a left ventricular ejection fraction (LVEF) of 35 percent or less to conventional therapy for CHF plus placebo (847 patients), conventional therapy plus amiodarone (845 patients), or conventional therapy plus a conservatively programmed, shock-only, single-lead ICD (829 patients). Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause. RESULTS: The median LVEF in patients was 25 percent; 70 percent were in NYHA class II, and 30 percent were in class III CHF. The cause of CHF was ischemic in 52 percent and nonischemic in 48 percent. The median follow-up was 45.5 months. There were 244 deaths (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death of 23 percent (0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007) and an absolute decrease in mortality of 7.2 percentage points after five years in the overall population. Results did not vary according to either ischemic or nonischemic causes of CHF, but they did vary according to the NYHA class. CONCLUSIONS: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa043399

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310

Flagged first, then by citations

Show all 20 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 201–300 of 1,019

The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
Marijon, É., Narayanan, K., Smith, K. L., Barra, S., Basso, C., Blom, M. T., Crotti, L., d’Ávila, A., Deo, R., Dumas, F., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00875-9 · Cited by 346
Anemia and Chronic Heart Failure
Anand, I. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.044 · Cited by 324
Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality
Friedmann, E., Thomas, S. A., Liu, F., Morton, P. G., Chapa, D., & Gottlieb, S. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.05.009 · Cited by 309
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
Iles, L., Pflüger, H., Lefkovits, L., Butler, M. J., Kistler, P. M., Kaye, D. M., & Taylor, A. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.062 · Cited by 305
Mechanical Dispersion Assessed by Myocardial Strain in Patients After Myocardial Infarction for Risk Prediction of Ventricular Arrhythmia
Haugaa, K. H., Smedsrud, M. K., Steen, T., Kongsgaard, E., Loennechen, J. P., Skjærpe, T., Voigt, J., Willems, R., Smith, G., Smiseth, O. A., et al. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.11.012 · Cited by 308
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.023 · Cited by 319
Self-citation
Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices
van Rees, J. B., de Bie, M. K., Thijssen, J., Borleffs, C. J. W., Schalij, M. J., & van Erven, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.007 · Cited by 306
Home Use of Automated External Defibrillators for Sudden Cardiac Arrest
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Toff, W. D., Tonkin, A. M., Smith, W., Dorian, P., Packer, D. L., White, R. D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801651 · Cited by 301
Self-citation
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
Wilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al-Khatib, S. M., Almendral, J., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.11.018 · Cited by 301
The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy
Becker, M. A. J., Cornel, J. H., van de Ven, P. M., van Rossum, A. C., Allaart, C. P., & Germans, T. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.03.006 · Cited by 300
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
Linde, C. M., Bongiorni, M. G., Birgersdotter-Green, U. M., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Gelder, I. C. V., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 308
Self-citation
Aggregate National Experience With the Wearable Cardioverter-Defibrillator
Chung, M. K., Szymkiewicz, S. J., Shao, M., Zishiri, E., Niebauer, M. J., Lindsay, B. D., & Tchou, P. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.016 · Cited by 297
Heart and Lung Transplantation Developed in Collaboration With the International Society for Guidelines Cardiology Foundation/American Heart Association Task Force on Practice Management of Heart Failure in Adults: A Report of the American College of 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and
Ganiats, T. G., Konstam, M. A., MANCINI, D. M., Abraham, W. T., Casey, D. E., Feldman, A. M., & Ma, G. S. (2009) · Cited by 297
Strain Echocardiography Improves Risk Prediction of Ventricular Arrhythmias After Myocardial Infarction
Haugaa, K. H., Grenne, B. L., Eek, C. H., Ersbøll, M. K., Valeur, N., Svendsen, J. H., Florian, A. R., Sjøli, B., Brunvand, H., Køber, L., et al. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.03.005 · Cited by 295
Ventricular arrhythmias and sudden cardiac death
John, R. M., Tedrow, U. B., Koplan, B. A., Albert, C. M., Epstein, L. M., Sweeney, M. O., Miller, A. L., Michaud, G. F., & Stevenson, W. G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61413-5 · Cited by 288
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.024 · Cited by 288
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients
Herzog, C. A., Mangrum, J. M., & PASSMAN, R. S. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00455.x · Cited by 290
Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome
Sacher, F., Probst, V., Iesaka, Y., Jacon, P., Laborderie, J., Mizon-Gérard, F., Mabo, P., Reuter, S., LAMAISON, D., Takahashi, Y., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.628537 · Cited by 290
The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators
Reynolds, M. R., Cohen, D. J., Kugelmass, A. D., Brown, P. P., Becker, E. R., Culler, S. D., & Simon, A. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.049 · Cited by 289
Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death
Curtis, L. H., Al‐Khatib, S. M., Shea, A. M., Hammill, B. G., Hernandez, A. F., & Schulman, K. A. (2007) · JAMA · doi:10.1001/jama.298.13.1517 · Cited by 289
Guidelines for cardiac pacing and cardiac resynchronization therapy
Vardas, P. E., Auricchio, A., Blanc, J., Daubert, J., Drexler, H., Ector, H., Gasparini, M., Linde, C. M., Morgado, F. B., Oto, A., et al. (2007) · EP Europace · doi:10.1093/europace/eum189 · Cited by 290
Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
Saxon, L. A., Bristow, M. R., BOEHMER, J. P., Krueger, S., Kass, D. A., Marco, T. D., Carson, P. E., DiCarlo, L. A., Feldman, A. M., Galle, E. G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.642892 · Cited by 290
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 302
Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry
Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000447 · Cited by 286
Complications Associated With Implantable Cardioverter-Defibrillator Replacement in Response to Device Advisories
Gould, P. A. (2006) · JAMA · doi:10.1001/jama.295.16.1907 · Cited by 284
Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy
Das, M. K., Maskoun, W., Shen, C., Michael, M. A., Suradi, H. S., Desai, M., Subbarao, R., & Bhakta, D. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.09.065 · Cited by 279
Skeletal Myoblast Transplantation in Ischemic Heart Failure
Hagège, A. A., Marolleau, J., Vilquin, J., Alhéritière, A., Peyrard, S., Duboc, D., Abergel, É., Messas, E., Mousseaux, É., Schwartz, K., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000521 · Cited by 278
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
Sweeney, M. O., Wathen, M. S., VOLOSIN, K. J., Abdalla, I., DeGroot, P., Otterness, M. F., & Stark, A. J. (2005) · Circulation · doi:10.1161/circulationaha.104.526673 · Cited by 275
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.005 · Cited by 284
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
Alter, P. J., Waldhans, S., PLACHTA, E., Moosdorf, R., & Grimm, W. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00195.x · Cited by 273
Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction
Bloomfield, D. M., Bigger, J. T., Steinman, R. C., Namerow, P. B., Parides, M. K., Curtis, A. B., Kaufman, E. S., Davidenko, J. M., Shinn, T., & Fontaine, J. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.026 · Cited by 270
Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection
Tseng, Z. H., Secemsky, E. A., Dowdy, D. W., Vittinghoff, E., Moyers, B., Wong, J. K., Havlir, D. V., & Hsue, P. Y. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.024 · Cited by 269
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction
Huikuri, H. V., Raatikainen, M. J. P., Moerch-Joergensen, R., Hartikainen, J., Virtanen, V., Boland, J., Anttonen, O., Hoest, N., Boersma, L. V. A., Platou, E. S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn537 · Cited by 264
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications
Nordkamp, L. R. A. O., Postema, P. G., Knops, R. E., van Dijk, N., Limpens, J., Wilde, A. A. M., & de Groot, J. R. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.010 · Cited by 267
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea
Ryan, C. M. (2005) · Thorax · doi:10.1136/thx.2005.040972 · Cited by 266
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure
Mark, D. B., Nelson, C. L., Anstrom, K. J., Al‐Khatib, S. M., Tsiatis, A. A., Cowper, P. A., Clapp‐Channing, N. E., Davidson-Ray, L. D., Poole, J. E., Johnson, G. W., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.581884 · Cited by 264
Self-citation
Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation
Gasparini, M., Auricchio, A., Metra, M., Regoli, F. D., Fantoni, C., Lamp, B., Curnis, A., Vogt, J., & Klersy, C. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn133 · Cited by 259
Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure
Mark, D. B., Anstrom, K. J., Sun, J. L., Clapp-Channing, N. E., Tsiatis, A. A., Davidson-Ray, L., Lee, K. L., & Bardy, G. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706719 · Cited by 260
Self-citation
Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator
Friedman, P. A., MURGATROYD, F. D., Boersma, L. V. A., Manlucu, J., O’Donnell, D., Knight, B. P., Clémenty, N., Leclercq, C., Amin, A. K., Merkely, B. P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206485 · Cited by 259
Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis
Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255
A Practical Guide for Clinicians Who Treat Patients with Amiodarone: 2007
Goldschlager, N., Epstein, A. E., Naccarelli, G. V., Olshansky, B., Singh, B. N., Collard, H. R., & Murphy, E. J. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.07.020 · Cited by 255
Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography Society of Nuclear Cardiology, Heart Rhythm Society, Society of Collaboration With the American Society of Echocardiography, American Cardiovascular Evaluation for Noncardiac Surgery): Developed in (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiology/American Heart Association Task Force on Practice Guidelines Care for Noncardiac Surgery: A Report of the American College of ACC/AHA 2007 Guidelines …
Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Buller, E., Creager, M. A., Ettinger, S. M., Faxon, D. P., Jacobs, A. K., Adams, C. D., et al. (2007) · Cited by 250
Self-citation
Sudden Cardiac Death and Arrhythmias
Srinivasan, N. T., & SCHILLING, R. J. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018:15:2 · Cited by 249
The ABCD (Alternans Before Cardioverter Defibrillator) Trial
Costantini, O., Hohnloser, S. H., KIRK, M. M., Lerman, B. B., Baker, J. H., Sethuraman, B., Dettmer, M. M., & ROSENBAUM, D. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.077 · Cited by 247
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction
Givertz, M. M., Stevenson, L. W., Costanzo, M. R., Bourge, R. C., Bauman, J. G., Ginn, G., & Abraham, W. T. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.010 · Cited by 253
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
Freemantle, N., Lafuente-Lafuente, C., Mitchell, S., Eckert, L., & Reynolds, M. (2011) · Europace · doi:10.1093/europace/euq450 · Cited by 245
2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4103 · Cited by 271
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)
Healey, J. S., Hohnloser, S. H., Glikson, M., Neuzner, J., Mabo, P., Viñolas, X., Kautzner, J., O’Hara, G. E., VanErven, L., Gadler, F., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61903-6 · Cited by 244
PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease
Khairy, P., Hare, G. F. V., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., de Groot, N. M. S., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.002 · Cited by 252
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure
Packer, D. L., Prutkin, J. M., Hellkamp, A. S., Mitchell, L. B., Bernstein, R. C., Wood, F., BOEHMER, J. P., Carlson, M. D., Frantz, R. P., McNulty, S. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.853689 · Cited by 243
Self-citation
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
Wilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al‐Khatib, S. M., Almendral, J. M., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2015) · EP Europace · doi:10.1093/europace/euv411 · Cited by 243
Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)
Kutyifa, V., Moss, A. J., Klein, H., Biton, Y., McNitt, S., MacKecknie, B., Zareba, W., & Goldenberg, I. (2015) · Circulation · doi:10.1161/circulationaha.115.015677 · Cited by 243
Cardiac Magnetic Resonance Assessment of Dyssynchrony and Myocardial Scar Predicts Function Class Improvement Following Cardiac Resynchronization Therapy
Bilchick, K. C., Dimaano, V. L. J., Wu, K. C., Helm, R. H., Weiss, R. G., Lima, J. A. C., Berger, R. D., Tomaselli, G. F., Bluemke, D. A., Halperin, H. R., et al. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.04.013 · Cited by 242
A Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators
Wilkoff, B. L., Ousdigian, K. T., Sterns, L. D., Wang, Z. J., Wilson, R. D., & Morgan, J. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.037 · Cited by 241
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy
Halliday, B. P., Cleland, J. G. F., Goldberger, J. J., & Prasad, S. K. (2017) · Circulation · doi:10.1161/circulationaha.116.027134 · Cited by 246
Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018)
Olsen, T., Jørgensen, O. D., Nielsen, J. C., Thøgersen, A. M., Philbert, B. T., & Johansen, J. B. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz316 · Cited by 238
Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy
Goldberger, J. J., Subačius, H., Patel, T., Cunnane, R., & Kadish, A. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.021 · Cited by 237
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.033 · Cited by 240
Chronic Heart Failure: Contemporary Diagnosis and Management
Ramani, G. V., Uber, P. A., & Mehra, M. R. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0494 · Cited by 243
Non–Evidence-Based ICD Implantations in the United States
Al‐Khatib, S. M. (2011) · JAMA · doi:10.1001/jama.2010.1915 · Cited by 232
Heart failure with reduced ejection fraction
Bloom, M. W., Greenberg, B., Jaarsma, T., Januzzi, J. L., Lam, C. S. P., Maggioni, A. P., Trochu, J., & Butler, J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.58 · Cited by 239
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome
Sarkozy, A., Boussy, T., Kourgiannides, G., Chierchia, G., Richter, S., Potter, T. D., Geelen, P., Wellens, F., Spreeuwenberg, M. D., & Brugada, P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl450 · Cited by 230
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality
Fonarow, G. C., Yancy, C. W., Hernandez, A. F., Peterson, E. D., Spertus, J. A., & Heidenreich, P. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.027 · Cited by 233
Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator
Goldenberg, I., Gillespie, J. A., Moss, A. J., Hall, W. J., Klein, H., McNitt, S. A., Brown, M. W., Cygankiewicz, I., & Zaręba, W. (2010) · Circulation · doi:10.1161/circulationaha.110.940148 · Cited by 230
Mode of Death in Advanced Heart Failure
Carson, P. E., Anand, I. S., O’Connor, C. J., Jaski, B. E., Steinberg, J. S., Lwin, A., Lindenfeld, J., Ghali, J., Barnet, J. H., Feldman, A. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.016 · Cited by 231
Cardiac Resynchronization Therapy
Kass, D. A. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.50136.x · Cited by 229
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., & McMurray, J. J. V. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn156 · Cited by 227
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, C., & Erdmann, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.05.046 · Cited by 236
Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol
Moss, A. J., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, M., Foster, E., Greenberg, H., Hall, W. J., Higgins, S. L., Klein, H., et al. (2005) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2005.00073.x · Cited by 230
Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation
Lee, D. S., Krahn, A. D., Healey, J. S., BIRNIE, D. H., Crystal, E., Dorian, P., Simpson, C. S., Khaykin, Y., CAMERON, D. A., Janmohamed, A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.029 · Cited by 226
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
Lindenfeld, J. M., Feldman, A. M., Saxon, L. A., BOEHMER, J. P., Carson, P. E., Ghali, J. K., Anand, I. S., Singh, S., Steinberg, J. S., Jaski, B. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.629261 · Cited by 225
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease
Fitzhugh, C. D., Lauder, N. N., Jonassaint, J., Telen, M. J., Zhao, X., Wright, E. C., Gilliam, F. R., & Castro, L. M. D. (2009) · American Journal of Hematology · doi:10.1002/ajh.21569 · Cited by 225
Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy
Chow, T., Kereiakes, D. J., Bartone, C. L., Booth, T., Schloss, E. J., Waller, T., Chung, E. S., Menon, S., Nallamothu, B. K., & Chan, P. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.079 · Cited by 225
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
Gold, M. R., Lambiase, P. D., El‐Chami, M. F., Knops, R. E., Aasbo, J. D., Bongiorni, M. G., Russo, A. M., Deharo, J., Burke, M. C., DINERMAN, J. L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048728 · Cited by 225
Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging
Cheong, B., Muthupillai, R., Wilson, J. M., Sung, A., Huber, S., Amin, S. K., Elayda, M. A., Lee, V., & Flamm, S. D. (2009) · Circulation · doi:10.1161/circulationaha.109.852517 · Cited by 220
The Entirely Subcutaneous Implantable Cardioverter-Defibrillator
Nordkamp, L. R. A. O., Abkenari, L. D., Boersma, L. V. A., Maass, A. H., de Groot, J. R., van Oostrom, A. J. H. H. M., Theuns, D. A. M. J., Jordaens, L. J. L. M., Wilde, A. A. M., & Knops, R. E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.053 · Cited by 222
Nonlinear and stochastic dynamics in the heart
Qu, Z., Hu, G., Garfinkel, A., & Weiss, J. N. (2014) · Physics Reports · doi:10.1016/j.physrep.2014.05.002 · Cited by 221
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R., Wang, H., Andrews, M. L., Mooney, C., Wang, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.032 · Cited by 221
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
Levy, W. C., Lee, K. L., Hellkamp, A. S., Poole, J. E., Mozaffarian, D., Linker, D. T., Maggioni, A. P., Anand, I. S., Poole-Wilson, P. A., Fishbein, D. P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.816884 · Cited by 221
Self-citation
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
Murtagh, G., Laffin, L. J., Beshai, J. F., Maffessanti, F., Bonham, C. A., Patel, A., Yu, Z., Addetia, K., Mor‐Avi, V., Moss, J. D., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003738 · Cited by 220
Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II
Goldenberg, I., Moss, A. J., Hall, W. J., McNitt, S. A., Zaręba, W., Andrews, M. L., & Cannom, D. S. (2006) · Circulation · doi:10.1161/circulationaha.105.577262 · Cited by 220
Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery
Bloom, H. L., Heeke, B., León, A. R., Mera, F. V., DeLurgio, D. B., Beshai, J. F., & Langberg, J. J. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00307.x · Cited by 219
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
Germano, J. J., Reynolds, M. R., Essebag, V., & Josephson, M. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.048 · Cited by 215
Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology
Budts, W., Roos‐Hesselink, J. W., Rädle‐Hurst, T., Eicken, A., McDonagh, T. A., Lambrinou, E., Crespo‐Leiro, M. G., Walker, F., & Frogoudaki, A. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv741 · Cited by 216
I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study
Agostini, D., Verberne, H. J., Burchert, W., Knuuti, J. M., Povinec, P., Sambuceti, G., Unlu, M., Estorch, M., Banerjee, G., & Jacobson, A. F. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0639-3 · Cited by 215
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
Jessup, M. L., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., MANCINI, D. M., Rahko, P. S., Silver, M. A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.009 · Cited by 221
ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation
Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Mario, C. D., Dickstein, K., Ducrocq, G., Fernández‐Avilés, F., et al. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.10.010 · Cited by 215
Effectiveness of Implantable Cardioverter-Defibrillators for the Primary Prevention of Sudden Cardiac Death in Women With Advanced Heart Failure
Ghanbari, H. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.255 · Cited by 213
How Sudden Is Sudden Cardiac Death?
Müller, D., Agrawal, R., & Arntz, H.-R. (2006) · Circulation · doi:10.1161/circulationaha.106.616318 · Cited by 213
Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction
Ikeda, T., Yoshino, H., Sugi, K., Tanno, K., Shimizu, H., Watanabe, J., Kasamaki, Y., Yoshida, A., & Kato, T. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.075 · Cited by 212
Comorbidity of atrial fibrillation and heart failure
Ling, L., Kistler, P. M., Kalman, J. M., SCHILLING, R. J., & Hunter, R. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.191 · Cited by 217
Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study
Gold, M. R., Theuns, D. A. M. J., Knight, B. P., Sturdivant, J. L., Sanghera, R., Ellenbogen, K. A., Wood, M. A., & Burke, M. C. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02199.x · Cited by 211
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials
Rivero‐Ayerza, M., Theuns, D. A. M. J., García‐García, H. M., Boersma, E. H., Simoons, M. L., & Jordaens, L. J. L. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl203 · Cited by 212
Prediction of Arrhythmic Events in Ischemic and Dilated Cardiomyopathy Patients Referred for Implantable Cardiac Defibrillator
Gao, P., Yee, R. K., Gula, L. J., Krahn, A. D., Skanes, A. C., Leong‐Sit, P., Klein, G. J., Stirrat, J., Fine, N. M., Pallaveshi, L., et al. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.971549 · Cited by 209
2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure
Authors Task Force Members, Dickstein, K., Vardas, P. E., Auricchio, A., Daubert, J.-C., Linde, C., McMurray, J., Ponikowski, P., Priori, S. G., Sutton, R., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq192 · Cited by 209
The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011
Kremers, M. S., Hammill, S. C., Berul, C. I., Koutras, C., Curtis, J. P., Wang, Y., Beachy, J., Blum, L., Conyers, D. M., Reynolds, M. R., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.01.035 · Cited by 209
Ventricular Tachycardia and Sudden Cardiac Death
Koplan, B. A., & Stevenson, W. G. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.3.289 · Cited by 215
Large, single-center, single-operator experience with transvenous lead extraction: Outcomes and changing indications
Jones, S. O., Eckart, R. E., Albert, C. M., & Epstein, L. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.01.009 · Cited by 205
Perioperative management of patients with cardiac implantable electronic devices
Stone, M. E., Salter, B. S., & Fischer, A. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer354 · Cited by 206

Authors: Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., & Ip, J. H.
Affiliations: The Seattle Institute for Cardiac Research (US)
Duke University (US)
University of Washington (US)
Mayo Clinic (US)
National Heart, Lung, and Blood Institute (US)
ORCID: Lee, Kerry L.
Mark, Daniel B.
Poole, Jeanne E.
Packer, Douglas L.
Boineau, Robin
Davidson-Ray, Linda D.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-01-20
Volume: 352
Issue: 3
Pages: 225-237
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa043399
OpenAlex: W2075175982
Semantic Scholar: cf04075b17dbae3fc6bc9a3a2f9673f9fad192ea
Cited by: 6,552
References: 20
Citations by year: 2026: 126 · 2025: 170 · 2024: 173 · 2023: 186 · 2022: 231 · 2021: 236 · 2020: 261 · 2019: 285 · 2018: 287 · 2017: 394 · 2016: 326 · 2015: 355 · 2014: 335 · 2013: 369 · 2012: 376
FWCI: 292.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (UO1 HL55297, UO1 HL55496, UO1 HL55766, U01HL055297, U01HL055766, U01HL055496)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: amiodarone, implantable cardioverter-defibrillator, congestive heart failure, sudden cardiac death, mortality, left ventricular ejection fraction, NYHA functional class, antiarrhythmic therapy
MeSH terms: Aged, Amiodarone, Anti-Arrhythmia Agents, Cause of Death, Female, Heart Failure, Humans, Male, Middle Aged, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks